Trial record 1 of 3 for: "Cicatricial Pemphigoid" | "Antirheumatic Agents"
Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00584935|
Recruitment Status : Completed
First Posted : January 2, 2008
Results First Posted : April 21, 2011
Last Update Posted : February 7, 2018
University of Alabama at Birmingham
Information provided by (Responsible Party):
Craig Elmets, University of Alabama at Birmingham
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Ocular Cicatricial Pemphigoid
Genentech closed trial before site was able to enroll 5 patients.